Presentation is loading. Please wait.

Presentation is loading. Please wait.

Instructions for making a CLIPS Card:PREVENTION

Similar presentations


Presentation on theme: "Instructions for making a CLIPS Card:PREVENTION"— Presentation transcript:

1 Instructions for making a CLIPS Card:PREVENTION
Use this 2 slide Powerpoint template following this intro slide to create the 2-sided CLIP session card you are working on. Remove this slide and the finished product with 2 slides (front and back) to Cristina at Name the presentation “CLIPS TOPIC NAME YEAR MADE” e.g. “CLIPS LIPID SCREENING 2015” Each card should take about 15 minutes to present/ask/discuss. Try wherever possible to include the name of the organization that makes the screening recommendation, NNT for screening Include information about important safety net programs where relevant: FPACT, CDP, BCCCP/BCCTP, low cost pharmacy programs, community resources, common barriers

2 Screening for Lipid Disorders (1)
C.L.I.P.S. Why do we screen? Treatment of HLD with statins reduces the risk of heart attack and stroke, absolute risk reduction depends on the level of risk at start Primary Prevention (those with no known CVD) Women >45 (A) Women with risk factors (B) Men >35 (A) Men with risk factors (B) Risk Factors include: HTN, Obesity, Tobacco, FHx, DM Interval for screening: q 5 years, sooner if high/borderline results Age to stop screening: not established, over 65: consider if never screened, other risk factors present(see above) Who makes these recommendation? USPSTF 2008 How do we screen ICD code has to be a condition or risk factor not V code In eCW, order “Lipid panel with reflex to direct LDL” non-fasting Order a follow up fasting test if TG were significantly elevated Clinical care tools for point of care AHRQ ePSS App (USPSTF guidelines) ASCVD Risk Calculator (Based on 2013 ACC/AHA guidelines) Algorhythym for treatment by AHA 2013 Consider asking if anyone has/uses these APPS What is the relative risk reduction of statins for primary prevention of CVD event? About 30% (an at-best estimate) Updated 5/15 T.Scott

3 Screening for Lipid Disorders (2)
C.L.I.P.S. How do you interpret the results? LDL-C >190 or TG >500 start high intensity statin all ages LDL-C with no DM, CAD, ASCVD Risk >7.5% moderate to high intensity statin This is displayed in the treatment algorhythm (make available) Put this algorhythm in favorites on the internet Interventions to reduce risk of CVD event Smoking cessation Exercise Dietary change: healthy oils and fats, fewer refined carbohydrates High-intensity statins: Partnership: Atorva 40-80*, Rosuvastatin (STEP) Target/Walmart: none available at high intensity SRCHC: none available at high intensity Moderate-intensity statins: Partnership: Atorva 10-20* Target/Walmart: Lova 40 SRCHC: Prava 40,Simva 20-40 Considerations for population management: PHP: What high- intensity statin is available through a $4 or low cost program? none


Download ppt "Instructions for making a CLIPS Card:PREVENTION"

Similar presentations


Ads by Google